Market Movers What Driving Today Top Stock Gainers

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  17 Mar 2025
 

vTv Therapeutics $VTVT shares skyrocketed over 53% after the U.S. Food and Drug Administration lifted a clinical hold on the company's Phase 3 diabetes treatment study. The trial focuses on cadisegliatin, an oral liver-selective glucokinase activator for type 1 diabetes that has shown promising results in over 500 subjects. The company plans to resume the CATT1 trial with a protocol amendment reducing its duration from 12 to 6 months, potentially accelerating the path to a New Drug Application. This regulatory green light represents a significant milestone for vTv's diabetes treatment pipeline and has clearly reinvigorated investor confidence.

CervoMed ($CRVO) shares climbed 40.53% despite reporting mixed financial results. While the company missed earnings expectations with a GAAP EPS of -$2.02 (falling short by $0.17), it exceeded revenue forecasts with $9.73 million (beating estimates by $0.39 million). The real catalyst behind the stock's surge appears to be positive 16-week results from the extension phase of its Phase 2b RewinD-LB trial for neflamapimod in dementia with Lewy bodies. The trial showed improvement on primary outcome measures, suggesting potential breakthrough treatment options for this challenging neurological condition.

Hyperfine ($HYPR) shares jumped 39.28% after announcing a strategic partnership with NVIDIA to advance AI-powered image reconstruction technology. This collaboration aims to enhance Hyperfine's Swoop system, the first FDA-approved AI-driven portable MRI, making brain imaging more accessible, affordable, and efficient worldwide. The partnership addresses a critical healthcare challenge, as over three billion people globally lack access to affordable and timely brain imaging. Investors are clearly optimistic about the potential of this collaboration to disrupt the medical imaging market.

In the technology sector, Wearable Devices ($WLDS) gained 33.59% after securing a patent for its gesture and voice-control technology. The patent protects the company's gesture-controlled interface that measures physical properties directly from the wrist, including capabilities like estimating object weight and measuring applied force. This intellectual property protection strengthens Wearable Devices' competitive position in the rapidly growing wearable technology market.

Chinese electric vehicle manufacturer Niu Technologies ($NIU) saw shares rise 29.04% following better-than-expected fourth-quarter results. Despite reporting a net loss, the company's financial position improved significantly compared to the previous year, with revenues climbing 71.1% year-over-year to RMB 819.2 million. E-scooter sales jumped 64.9% compared to the same period last year, and the company provided encouraging guidance for Q1 2025. The robust growth in Niu's core business, particularly in the Chinese market, appears to be driving renewed investor interest.

Quantum computing stocks also showed strength, with Quantum Computing Inc. ($QUBT) gaining 13.12% and D-Wave Quantum ($QBTS) rising 10.15%. The quantum computing sector has been experiencing increased investor attention as the technology approaches practical applications. For $QUBT, new options became available for the March 21st expiration, potentially driving increased trading activity. D-Wave has been a hot stock recently, though some analysts remain cautious about its valuation relative to its fundamentals.

Mining company Contango Ore ($CTGO) rounded out the top gainers with a 12.33% increase despite reporting a GAAP EPS of -$3.49. The company, which focuses on gold and associated minerals in Alaska, appears to be benefiting from broader market sentiment toward precious metals as inflation concerns persist.